AbbVie’s antibody-drug conjugate Elahere on Friday won the FDA’s full approval for the treatment of FRα-positive, platinum-resistant ovarian, fallopian tube and primary peritoneal cancers.
We have built molds and customized products for more than 20 customers from US, UK, France, Sweden, Italy, Spain, Australia, Philippines, Thailand, etc.24 hours service quick response Please contact us...
We have built molds and customized products for more than 20 customers from US, UK, France, Sweden, Italy, Spain, Australia, Philippines, Thailand, etc.24 hours service quick response Please contact us at any time and we will answer withi...